Adiponectin is the most useful predictor for all-cause mortality and recurrence of acute coronary syndrome in patients with acute myocardial infarction

Nakashima, Hiroshi; Henmi, Tomoko; Minami, Kazutoshi; Uchida, Yuzou; Shiraishi, Y.; Nunohiro, Tatsuya; Takeshita, Satoshi; Maemura, Koji

doi:10.1093/eurheartj/eht308.p1315

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, one of the key concerns of the clinician is to identify and manage risk factors in order to minimize the risk of mortality. To date, researchers have found that vitamin D levels [27], education level [28], posttraumatic stress [29], and adiponectin [30] are risk predictors of all-cause mortality.…”

Section: Discussionmentioning

confidence: 99%

Baseline Serum Uric Acid Levels Are Associated with All-Cause Mortality in Acute Coronary Syndrome Patients after Percutaneous Coronary Intervention

Lü

Long

et al. 2018

Disease Markers

View full text Add to dashboard Cite

Background Whether serum uric acid (UA) is associated with all-cause mortality in patients with acute coronary syndrome (ACS) following percutaneous coronary intervention (PCI) remains unclear. Methods We performed a retrospective cohort study of 2296 patients with ACS. Curve-fitting and Cox proportional-hazard regression models with a hazard ratio (HR) and 95% confidence interval (CI) were used. Results During a mean follow-up of 246.31 ± 49.16 days, 168 (7.32%) patients died from all causes. Patients were divided into two groups [the high-UA group (n = 566) and the low-UA group (n = 1730)] based on the serum UA threshold value (5.6 mg/dl) identified through curve fitting. Fifty-three (9.36%) patients died in the high-UA group, and 115 (6.65%) patients died in the low-UA group. The difference between groups was statistically significant (P = 0.031). Univariate analysis showed that the risk of all-cause mortality in the high-UA group was significantly greater than that in the low-UA group (HR = 1.45, 95% CI: 1.03 to 2.04). This difference persisted after adjustment for baseline characteristics, medical history, and medication history (HR = 1.42, 95% CI: 1.05 to 1.87). Conclusions Our study demonstrated that elevated serum UA (>5.6 mg/dl) is associated with all-cause mortality in ASC patients after PCI.

show abstract